The same story goes for its figure-eight performance. 21.9 seconds at 1.08 cumulative average g is a supercar number, but it puts the ZR1X in a seven-way tie for fifth. Meanwhile, the standard ZR1 ...
Sana Biotechnology Inc. (NASDAQ:SANA) is one of the most promising penny stocks under $5 to buy. On February 17, Sana ...
In a suit filed at the High Court in Accra, the plaintiff argued that Vivo Energy owed a duty of care to ensure that fuel sold at its stations meets required standards. He alleged that this duty “was ...
Neoadjuvant pembrolizumab (3 doses) in stage I–III disease yielded a 71% pCR rate and only one melanoma-specific survival event at 3 years post-resection. Experts discuss the SWOG S1512 trial of ...
Gene therapy and gene editing are marvels of modern biotechnology, providing revolutionary techniques for fixing genetic abnormalities. Gene therapy introduces functional genetic material to ...
CAR-T therapies have changed the oncology space, but their cost and complexity have confined these treatments to specialized ...
A new editorial perspective was published in Volume 17 of Oncotarget on February 20, 2026, titled "CAR-T therapy: Trailblazing CAR(ing) in cancer treatment." ...
GenEdit is sailing toward the clinic with a new name and fresh funding. | GenEdit is sailing toward the clinic with a new name and fresh funding. Rebranded as BreezeBio, the biotech has raised $60 ...
The Chosun Ilbo on MSN
In vivo CAR-T offers single-injection cancer treatment hope
Will a world where cancer is treated with a single injection arrive? The so-called ‘in vivo CAR-T’ method, which directly alters immune cells within the body, is recently transforming the cancer ...
The central question is no longer whether we can innovate, but whether innovation can truly reach patients in time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results